Terbinafine is considered the gold standard in the treatment of dermatophytosis, but pathogenic dermatophytes that are resistant to terbinafine pose a new threat. A Swiss research team involving the Department of Dermatology at Lausanne University Hospital (CHUV) conducted a study to determine the proportion of resistant skin fungi, analyze the molecular mechanisms of terbinafine resistance and validate a method for reliable and rapid identification.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Obstructive sleep apnea syndrome
Fitness to drive with OSAS
- Post-COVID
Complaints from a neurological point of view
- Smoking cessation
On the way to better health – alternative nicotine products in view
- Age-related cognitive impairments
Ginkgo biloba extracts bring benefits
- Casuistry
SLE with kidney damage does not always have to be lupus nephritis
- Viral hepatitis
Hepatitis ABC(EN): Prophylaxis and treatment – an update
- Type 2 diabetes: reduction of microvascular and macrovascular risks
The extensive toolbox has a lot to offer
- Practice Management